A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer.
about
A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
A cyclin-dependent kinase inhi ...... ment models of thyroid cancer.
@ast
A cyclin-dependent kinase inhi ...... ment models of thyroid cancer.
@en
type
label
A cyclin-dependent kinase inhi ...... ment models of thyroid cancer.
@ast
A cyclin-dependent kinase inhi ...... ment models of thyroid cancer.
@en
prefLabel
A cyclin-dependent kinase inhi ...... ment models of thyroid cancer.
@ast
A cyclin-dependent kinase inhi ...... ment models of thyroid cancer.
@en
P2093
P2860
P1433
P1476
A cyclin-dependent kinase inhi ...... ment models of thyroid cancer.
@en
P2093
Chuen Hsueh
Jen-Der Lin
Richard J Wong
Ting-Chao Chou
P2860
P304
P356
10.1371/JOURNAL.PONE.0172315
P407
P50
P577
2017-02-16T00:00:00Z